Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision label v3.3.2 is added as the latest entry in the study record history, replacing v3.2.0. This is a record-keeping update that does not affect the study content.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding/operating status notice from the page. This change does not affect the study data or the record history.SummaryDifference0.7%

- Check34 days agoChange DetectedVersion 6 (2024-06-26) was added, showing updates to Study Status, Study Design, Outcome Measures, and Adverse Events. It includes a note that the Quality Control Review Has Not Concluded and indicates Returned: 2024-06-24.SummaryDifference0.1%

- Check62 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference12%

- Check69 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. No other page content appears affected.SummaryDifference0.3%

- Check84 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.7%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.